Sartorius Stedim Biotech launches Integrated Solutions online resource center
New website will support clients in developing and implementing entire single-use bioprocesses.
Sartorius Stedim Biotech has launched its Integrated Solutions website, an online resource and information centre to support its clients as they develop and implement entire single-use or hybrid biomanufacturing processes.
The new website is designed to assist clients in the implementation of flexible, scalable and cost-efficient bioprocesses by utilizing the tools, technologies, support and expertise available from Sartorius Stedim Biotech. To allow clients to better understand the effectiveness with which Integrated Solutions can be applied to their bioprocesses a comprehensive portfolio of case studies are available from companies such as Boehringer Ingelheim, Wuxi AppTec, Mabion, DMBio and Bayer.
The biopharmaceutical industry is being forced to adapt to changing and challenging market conditions. Reducing costs and increasing process optimization are becoming increasingly important due to pressures from healthcare providers and competition from biosimilars. Sartorius Stedim Biotech’s new Integrated Solutions website describes how the company addresses these challenges through partnering with clients to design and develop entire single-use and hybrid processes for the manufacture of biopharmaceuticals. Process development activities are coordinated by a team of process development consultants utilizing an array of technologies and software tools while the design and engineering of the large-scale bioprocess is performed by a separate, dedicated team that have successfully completed over 100 fully single-use projects.
Ensuring clients benefit from the shortest time to market, Sartorius Stedim Biotech is using the Integrated Solutions website to showcase its new ‘mAb Process Platform’. The new platform is a result of the company’s innovative ‘Process4Success’ initiative which seeks to leverage both novel single-use processing technologies and the expertise within the organization to define sequences of unit operations that can be combined to create an entire bioprocess line.
Multiple client testimonials are available on the new resource center describing how the Integrated Solutions approach has already been successfully applied to a number of diverse collaborative projects. For example, speaking of a recent collaboration between Sartorius Stedim Biotech and Boehringer Ingelheim, Jan Feuser (Head of Clinical Supply Facility Downstream at Boehringer Ingelheim) said: “The ability to work across different sites at a global scale with one Boehringer Ingelheim project team and one Sartorius project team, truly enabled the success of the project.“
Related News
-
News WuXi to sell CGT manufacturing unit to US-based Altaris LLC
At the tail end of 2024, Chinese-based CDMO WuXi AppTec announced the signing of their deal with private equity firm Altaris LLC, confirming the sale of WuXi Advanced Therapies, the cell and gene therapy manufacturing arm of WuXi AppTec. -
News Women in Pharma: Our hopes for 2025 and beyond
Our last instalment for 2024 of the Women in Pharma series brings you messages direct from the Informa Markets CPHI team as they discuss the advice and insights they have carried throughout their roles working at CPHI, and what they hope to see for the... -
News CPHI Milan Wrap-Up Report: Conference Highlights
Discover the emerging and trending topics of the pharmaceutical industry with our CPHI Milan Conference Highlights, with exclusive insight from pharmaceutical leaders and experts! -
News BIOSECURE Act not included in key defense spending bill for 2025
On December 7, 2024, the Biden administration revealed the 2025 National Defense Authorization Act, an annual defense bill specifying the budget and expenditures of the US Department of Defense. The controversial BIOSECURE Act was notably missing from ... -
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News Trump 2.0: What does the US election result mean for the healthcare industry?
After Trump won the Presidential election in the US in early November, we take a look at some of the implications a new Trump administration could have on the health and pharmaceutical industry, and on US patients. -
News Women in Pharma: Reflections from Behind the Scenes
In this instalment of our monthly series, the team that brings you the Women in Pharma series each month sits down for a heart-to-heart on what the series means to them, and how they hope to continue their work in the future. -
News Scaling the Industry: CPHI Scale-Up Market interview with YSK Laboratories
For the first time, CPHI Milan hosted the CPHI Start-Up Market, expanding support for emerging and small-sized enterprises in their transition to the next level of growth. In this interview, we spoke with Yuvansh Khokhani, Managing Director of YSK Labo...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance